This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

ASCP Corner

Is the Problem of a High Placebo Response Unique to Antidepressant Trials?

Arif Khan, MD, and Amritha Bhat, MBBS, MD

Published: December 31, 2008

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Recent studies questioning the effectiveness of antidepressantshave received considerable attention in the mass media.These articles report the difficulty in demonstrating superiorityof antidepressants over placebo among antidepressant trials.Interestingly, placebo response also plays a significant role intrials of other nonpharmacologic somatic treatments for depressionas well as treatments for many other chronic psychiatricand nonpsychiatric illnesses; however, this does not seem tohave received similar attention.’ ‹

Volume: 69

Quick Links: Assessment Methods , Research Methods Statistics

Continue Reading…

Subscribe to read the entire article


Buy this Article as a PDF

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...